• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

J.P. Morgan Healthcare Conference

Diabetes unit continues to power growth at Abbott with Lingo coming to U.S. ‘soon’

January 12, 2024 By Sean Whooley

With continued progress on established platforms, new acquisitions and new products, Abbott has high expectations for its Diabetes business. Speaking at the J.P. Morgan Healthcare Conference, CEO Robert Ford highlighted diabetes as a key area for near-term growth. Specifically, in the presentation transcribed by SeekingAlpha, Ford said he expects the FreeStyle Libre continuous glucose monitor […]

Filed Under: Business/Financial News, Diabetes, Drug Pumps, Drug-Device Combinations, Health Technology, Patient Monitoring Tagged With: Abbott, J.P. Morgan Healthcare Conference

The biggest stories from the 2024 J.P. Morgan Healthcare Conference

January 11, 2024 By Sean Whooley

Some of the biggest names in medtech came together this week at the J.P. Morgan Healthcare Conference. They shared updates on financial progress, operational changes and new products, among other things. Medtronic shared details on plans to restore earnings power, while Abbott highlighted the success of its FreeStyle Libre system. Shockwave Medical outlined its plans […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Diabetes, Featured, Health Technology, In-Depth Coverage, News Well, Pulsed-Field Ablation (PFA), Special Content, Structural Heart Tagged With: Abbott, Dexcom, Insulet, J.P. Morgan Healthcare Conference, Johnson & Johnson, Johnson & Johnson MedTech, Medtronic, Shockwave Medical

Shockwave Medical plans for growth with 2-3 product launches each year

January 10, 2024 By Sean Whooley

It was a busy 2023 for Shockwave Medical (Nasdaq:SWAV), with product launches, funding rounds and M&A at the heart of it. The company, which develops intravascular lithotripsy (IVL) technology, first made waves last year with its acquisition of Neovasc. Neovasc develops the Reducer system for addressing refractory angina. Shockwave remained in the middle of M&A […]

Filed Under: Business/Financial News, Cardiovascular, Catheters, Featured, News Well, Vascular Tagged With: J.P. Morgan Healthcare Conference, Shockwave Medical

Medtronic CEO: ‘Our top priority is restoring our earnings power — full stop.’

January 8, 2024 By Jim Hammerand

Medtronic Chair and CEO Geoff Martha focused on the push for profits at the world’s largest medical device manufacturer in his presentation at the J.P. Morgan Healthcare Conference today. “Our top priority is restoring our earnings power — full stop,” he said, citing Medtronic’s recent reorganizations and changes to incentives, product approvals and launches, and […]

Filed Under: Business/Financial News, Diabetes, Featured, In-Depth Coverage, News Well, Special Content, Structural Heart Tagged With: cardiac ablation, Electrophysiology, J.P. Morgan Healthcare Conference, Medtronic

Mako’s Q4 turnaround has Stryker feeling confident

January 15, 2015 By Brian Johnson Leave a Comment

Mako's Q4 turnaround has Stryker feeling confident

Stryker (NYSE:SYK) posted a stellar quarter of sales for the robotic surgical system it acquired in its $1.7 billion deal for Mako Surgical.

Filed Under: Mergers & Acquisitions, News Well, Surgical Robotics Tagged With: J.P. Morgan Healthcare Conference, MAKO Surgical Corp., Smith & Nephew, Stryker

St. Jude Medical delivers ‘solid and uncontroversial’ Q4 prelims

January 15, 2015 By Brian Johnson Leave a Comment

St. Jude Medical delivers 'solid and uncontroversial' Q4 prelims

Filed Under: MassDevice Earnings Roundup, News Well Tagged With: J.P. Morgan Healthcare Conference, stjudemedical

Stryker eyes acquisitions, market share growth in Europe

January 14, 2015 By MassDevice Contributors Network Leave a Comment

Stryker eyes acquisitions, market share growth in Europe

Filed Under: News Well, Orthopedics Tagged With: J.P. Morgan Healthcare Conference, Stryker

Stryker CEO Lobo skeptical on ‘repless’ generic sales models

January 14, 2015 By Brian Johnson Leave a Comment

Stryker CEO Lobo skeptical on 'repless' generic sales models

Filed Under: News Well, Orthopedics Tagged With: J.P. Morgan Healthcare Conference, Sales, Smith & Nephew, Stryker, wrightmedical

Boston Scientific CEO looks to double emerging market sales

January 13, 2015 By Brian Johnson Leave a Comment

Boston Scientific CEO looks to double emerging markets sales

Filed Under: Emerging Markets, News Well Tagged With: Boston Scientific, J.P. Morgan Healthcare Conference

Smith & Nephew CEO Bohuon: Big not always beautiful

January 13, 2015 By MassDevice Contributors Network Leave a Comment

Smith & Nephew CEO Bohuon: Big not always beautiful

Filed Under: Mergers & Acquisitions, News Well Tagged With: J.P. Morgan Healthcare Conference, Smith & Nephew, Stryker

Medtronic CEO: ‘Covidien deal will help us do for ORs what we’ve done for cath labs’

January 12, 2015 By Brian Johnson Leave a Comment

Medtronic CEO Ishrak defends Covidien deal

Almost exactly a year ago Medtronic (NYSE:MDT) CEO Omar Ishrak insisted that value-based healthcare is the salvation, not the damnation, of the medical device industry.

Filed Under: Emerging Markets, Mergers & Acquisitions, News Well Tagged With: Covidien, J.P. Morgan Healthcare Conference, Medtronic buys Covidien

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 5
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy